JUL 29, 2016 8:02 AM PDT

Wheat Sensitivity Linked to Weakened Intestinal Barrier

WRITTEN BY: Carmen Leitch
Wheat sensitivity and gluten free foods have become a popular topic subject to a lot of debate. While celiac disease has been definitively linked to wheat intolerance, many people without a diagnosis of the disease report sensitivity to wheat. A new study in the journal Gut by researchers at Columbia University Medical Center (CUMC) now suggests that some people have a weakened intestinal barrier, and after ingesting wheat, those individuals experience inflammation throughout their body. These findings may come as a relief to lots of those who have struggled to make sense of their condition.
Wheat can wreak havoc on the digestive system, and not only those with celiac disease. / Credit: public-domain-image.com
"Our study shows that the symptoms reported by individuals with this condition are not imagined, as some people have suggested," explained one author of the work, Peter H. Green, MD, the director of the Celiac Disease Center and a Professor of Medicine at CUMC. "It demonstrates that there is a biological basis for these symptoms in a significant number of these patients."

Celiac disease, explained in the short video below, is an autoimmune disease resulting from genetic susceptibility. When people with the disorder consume grains like wheat, barley or rye, their immune system attacks the lining of the small intestine, resulting in a range of gastrointestinal problems like bloating, abdominal pain and diarrhea.
However, many people who do not display any of the hallmarks of celiac disease in their tissue, blood or genetic makeup still have symptoms like those seen in celiac. Those include the gastrointestinal symptoms, but also systemic issues like mood disturbances, fatigue or cognitive difficulties following ingestion of wheat, barley or rye.  This condition has been described as non-celiac wheat sensitivity (NCWS) – in which the grains cause acute, systemic immune activation. No biomarkers exist for the disorder, but it’s estimated that it has around the same prevalence as celiac disease – one percent of the U.S. population, about three million people. In the longer video below, Michael Albertson, MD of UCLA Health discusses both celiac disease and non-celiac gluten sensitivity.
To learn more about the condition, the investigators compared several groups – 40 healthy people, 40 with celiac disease and 80 with NCWS. They found that although celiac disease can cause extensive intestinal damage, no indication of innate systemic immune activation was seen (by analyzing blood) in the group with celiac disease. That suggests that celiac patients are able to neutralize microbes or microbial components that may pass through the damaged intestinal barrier using their intestinal immune response, thus preventing a systemic inflammatory response.

The group with NCWS, however, was very different. They carried a marker of intestinal cellular damage that was different from celiac patients but still correlates with indicators of acute systemic immune activation. That data suggests that systemic immune activation observed in NCWS is associated with an increased movement of microbial and dietary components from the gut, where they should normally stay, into circulation, where they can result in immune activation. That translocation is due in part to damage to and weakening of the wall of cells that forms the intestinal barrier.

"A systemic immune activation model would be consistent with the generally rapid onset of the reported symptoms in people with non-celiac wheat sensitivity," said the leader of the study, Armin Alaedini, Assistant Professor of Medicine at CUMC.

Interestingly, NCWS patients that eliminated wheat and related grains from their diet for six months actually normalized their levels of both immune activation and intestinal cell damage markers. Using detailed questionnaires, the scientists found that those changes were linked to big improvements in all symptoms.

Dr. Alaedini added, "The data suggest that, in the future, we may be able to use a combination of biomarkers to identify patients with non-celiac wheat sensitivity, and to monitor their response to treatment."

If you'd like more information, check out the website of the Celiac Disease Center at Columbia University.

Sources: AAAS/Eurekalert!, Columbia University, Gut
 
About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
OCT 04, 2021
Cancer
Predicting Progression-Free Survival in a Melanoma Study
OCT 04, 2021
Predicting Progression-Free Survival in a Melanoma Study
IsoPlexis’ Single-Cell Proteomics Predict Progression-Free Survival in Melanoma Study While advancements in oncolo ...
SEP 14, 2021
Microbiology
Learn How Good Bugs Can Benefit Us at International Microorganism Day
SEP 14, 2021
Learn How Good Bugs Can Benefit Us at International Microorganism Day
Microorganisms live everywhere, and we've learned over the past year that they can affect everything.
SEP 27, 2021
Microbiology
Rift Valley Fever's Infectious Secret is Revealed
SEP 27, 2021
Rift Valley Fever's Infectious Secret is Revealed
Rift Valley fever virus is carried by mosquitoes, and when it's passed to livestock including cattle, goats, and sheep, ...
SEP 27, 2021
Genetics & Genomics
DNA Gives Clues to the Mystery of 'Skeleton' Lake
SEP 27, 2021
DNA Gives Clues to the Mystery of 'Skeleton' Lake
While this research has provided some answers, it also raised many new questions. An image by Atish Waghwase/Harney et a ...
OCT 07, 2021
Cancer
Dual Threat: CAR T Cells Modified to Target Two Neuroblastoma Antigens
OCT 07, 2021
Dual Threat: CAR T Cells Modified to Target Two Neuroblastoma Antigens
Neuroblastoma is a cancer of immature nerve cells found in various areas, including the adrenal glands, neck, chest ...
OCT 10, 2021
Cell & Molecular Biology
DNA Can Reveal Treatments for Lung Cancer in 'Never-Smoked' Patients
OCT 10, 2021
DNA Can Reveal Treatments for Lung Cancer in 'Never-Smoked' Patients
There is a well-known causal connection between smoking and lung cancer, and most research on lung cancer has been focus ...
Loading Comments...